GSK EBIT 2010-2024 | GSK

GSK EBIT for the quarter ending September 30, 2024 was $0.246B, a 90.04% decline year-over-year.

  • GSK 2023 EBIT was 8.39B, a 5.44% increase from 2022.
  • GSK 2022 EBIT was 7.957B, a 6.68% decline from 2021.
  • GSK 2021 EBIT was 8.527B, a 14.67% decline from 2020.

EBIT can be defined as earnings before interest and taxes.

GSK EBIT 2010-2024 | GSK

  • GSK 2023 EBIT was 8.39B, a 5.44% increase from 2022.
  • GSK 2022 EBIT was 7.957B, a 6.68% decline from 2021.
  • GSK 2021 EBIT was 8.527B, a 14.67% decline from 2020.

EBIT can be defined as earnings before interest and taxes.